ETPrime

Ganga Pharmaceuticals Share Price

  • 14.60
  • Volume: 8,000
BSE
  • Closed
  • Last Updated On: 03 Sep, 2025, 04:00 PM IST
High: "NaN",Open: "NaN",Low: "NaN",
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Ganga Pharmaceuticals Share Price
  • 14.60
  • Volume: 8,000
Advertisment

Key Metrics

PE Ratio
(x)		0.00
EPS - TTM
(₹)		0.00
MCap
(₹ Cr.)		8.63
Sectoral MCap Rank
-
PB Ratio
(x)		-
Div Yield
(%)		0.00
Face Value
(₹)		-
Beta

Beta

1 Month-
3 Months-
6 Months-
1 Year-
3 Years-

-
VWAP
(₹)		-
52W H/L
(₹)
28.49 / 5.00

Ganga Pharmaceutical share price insights

  • Company has spent 6.77% of its operating revenues towards interest expenses and 21.88% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Share PriceValue
    Today/Current/Last-14.60
    Previous Day-14.60

InsightsGanga Pharmaceutical

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Ganga Pharmaceutical Share Price Returns

    1 Day0.0%
    1 WeekN.A.
    1 MonthN.A.
    3 MonthsN.A.
    1 YearN.A.
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Ganga Pharmaceutical belongs to analysts' top-rated companies list?

    View Stock Screeners

    Ganga Pharmaceutical News & Analysis

    View all Ganga Pharmaceutical Share News & Announcements

    Ganga Pharmaceutical Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Ganga Pharmaceutical Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 6.77% of its operating revenues towards interest expenses and 21.88% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue3.072.982.882.752.63
      Total Revenue Growth (%)3.293.154.984.53-18.97
      Total Expenses2.982.912.832.702.59
      Total Expenses Growth (%)2.292.855.014.06-13.30
      Profit after Tax (PAT)0.080.050.040.040.02
      PAT Growth (%)69.5218.603.7486.15-89.22
      Operating Profit Margin (%)10.359.069.539.889.75
      Net Profit Margin (%)2.991.701.511.520.85
      Basic EPS (₹)0.160.110.100.090.05

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets8.978.657.988.007.66
      Total Assets Growth (%)3.708.40-0.254.441.19
      Total Liabilities1.841.602.532.582.29
      Total Liabilities Growth (%)15.00-36.76-1.9412.663.62
      Total Equity7.137.055.455.415.37
      Total Equity Growth (%)1.1329.360.740.740.37
      Current Ratio (x)4.284.812.722.912.86
      Total Debt to Equity (x)0.200.190.340.330.29
      Contingent Liabilities-----

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities-0.58-1.26-0.04-0.21-0.18
      Net Cash used in Investing Activities1.180.130.490.190.28
      Net Cash flow from Financing Activities-0.331.14-0.440.03-0.10
      Net Cash Flow0.278,290.000.010.010.00
      Closing Cash & Cash Equivalent0.300.030.030.020.01
      Closing Cash & Cash Equivalent Growth (%)913.762.8641.8540.8824.33
      Total Debt/ CFO (x)-2.46-1.07-45.82-8.60-8.88

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)1.100.660.720.700.37
      Return on Capital Employed (%)3.703.324.053.893.82
      Return on Assets (%)0.880.530.490.470.26
      Interest Coverage Ratio (x)1.791.611.561.541.19
      Asset Turnover Ratio (x)0.300.330.320.3230.99
      Price to Earnings (x)62.50256.41147.06111.11151.52
      Price to Book (x)0.691.671.040.770.57
      EV/EBITDA (x)18.8944.2024.6119.8016.09
      EBITDA Margin (%)12.1210.8611.7112.0812.01

      No reported Financial Ratios are available.

    Financial InsightsGanga Pharmaceutical

    • Income (P&L)

      • Employee & Interest Expense

        Company has spent 6.77% of its operating revenues towards interest expenses and 21.88% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Ganga Pharmaceutical Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Ganga Pharmaceutical Peer Comparison

    Peers InsightsGanga Pharmaceutical

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Ganga Pharmaceutical Shareholding Pattern

      • Loading...
        Showing Ganga Pharmaceutical Shareholding as on Sep 2025
        CategorySep 2025Mar 2025Sep 2024Mar 2024
        Promoters50.9156.0256.0256.02
        Pledge0.000.000.000.00
        FII0.000.000.000.00
        DII0.000.000.000.00
        Mutual Funds0.000.000.000.00
        Others49.0943.9843.9843.98
      • Showing Shareholding as on Sep 2025
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters30,09,55050.91 %-5.11
        Pledge00.00 %0.00
        Others29,01,95049.09 %5.11

      Ganga Pharmaceutical MF Ownership

      MF Ownership details are not available.

      Top Searches:
      Ganga Pharmaceutical News Ganga Pharmaceutical Quarterly Results Ganga Pharmaceutical Dividend Ganga Pharmaceutical Q1 ResultsGanga Pharmaceutical Q2 ResultsGanga Pharmaceutical Q3 ResultsGanga Pharmaceutical Q4 Results

      Ganga Pharmaceutical Corporate Actions

      • Meeting DateAnnounced onPurposeDetails
        Sep 20, 2025Aug 20, 2025AGM-
        May 20, 2025May 06, 2025Board MeetingAudited Results
        Nov 08, 2024Nov 05, 2024Board MeetingHalf Yearly Results
        Sep 25, 2024Aug 07, 2024AGMBook closure from Sep 19, 2024 to Sep 25, 2024
        May 16, 2024May 06, 2024Board MeetingAudited Results

      • Dividend announcements are not available.

      • No other corporate actions details are available.

      About Ganga Pharmaceutical

      • Executives

      • Auditors

      • SV

        Sanjay Vyankatesh Kulkarni

        Chairman & Non-Exe.Director
        BB

        Bharat Brijmohan Sharma

        Managing Director & CEO
        SB

        Srijna Bharat Sharma

        Whole Time Director
        AM

        Aman Mukesh Chaudhari

        Independent Director
        Show More
      • Banka & Banka
        Anil Bansal & Co.
        Amarnath Sharma & Co

      Industry

      Pharma - Indian

      Key Indices Listed on

      -

      Address

      Gangatat, Dhanvantary Marg,Gopcharpada,Virar (East),Palghar, Maharashtra - 401305

      Contact

      [email protected]

      www.ayurvedganga.com

      More Details

      FAQs about Ganga Pharmaceutical share

      • 1. What's Ganga Pharmaceutical share price today and what are Ganga Pharmaceutical share returns ?
        Ganga Pharmaceutical share price is Rs 14.60 as on 03 Sep, 2025, 04:00 PM IST. Ganga Pharmaceutical share price is remain unchanged by N.A. based on previous share price of Rs 14.6. Ganga Pharmaceutical share price trend:
        • Last 3 Years: Ganga Pharmaceutical Share price moved remain unchanged by N.A.
      • 2. What is the PE & PB ratio of Ganga Pharmaceutical?
        The PE ratio of Ganga Pharmaceutical stands at null, while the PB ratio is 1.08.
      • 3. What has been highest price of Ganga Pharmaceutical share in last 52 weeks?
        Ganga Pharmaceutical share price saw a 52 week high of Rs 28.49 and 52 week low of Rs 5.00.
      • 4. What's the market capitalization of Ganga Pharmaceutical?
        Within the Pharmaceuticals sector, Ganga Pharmaceutical stock has a market cap rank of -. Ganga Pharmaceutical has a market cap of Rs 8.63 Cr.

      Trending in Markets

      Top Gainers As on 03:59 PM | 16 Oct 2025

      BLS Int. Services324.50
      45.95 (16.50%)
      Craftsman Automation6,800.50
      376.50 (5.87%)
      Oberoi Realty1,687.10
      85.70 (5.36%)
      Apar Industries8,784.50
      429.00 (5.14%)
      Ola Electric Mobilit55.38
      2.64 (4.99%)

      Top Losers As on 03:59 PM | 16 Oct 2025

      KEI Industries4,172.60
      -248.00 (-5.62%)
      Anant Raj633.35
      -29.20 (-4.41%)
      Netweb Technologies3,760.20
      -172.21 (-4.38%)
      Tata Investment906.00
      -35.00 (-3.72%)
      Max Financial1,552.40
      -56.70 (-3.53%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      Business News›Markets›Stocks›Stock Price Quotes›Ganga Pharmaceutical Share Price
      The Economic Times
      BrowseCompanies: